Navigation Links
Reversal of Fate: Hisense Medical Equipment Pivotal in Saving of a Two-year-old Child with Liver Cancer
Date:12/11/2013

QINGDAO, China, Dec. 11, 2013 /PRNewswire/ -- A 2-year-old child with a large liver tumor, a case that had been deemed as hopeless by several large hospitals, underwent surgery to successfully remove the tumor in Qingdao on Dec 3. With the help of medical equipment from Hisense Higemi, the high-risk and complicated liver tumor resection surgery took only three hours rather than traditional seven+ hours, with just 30 ml of blood loss during resection. The surgery represented Hisense Higemi's first application of its equipment in an operating room setting within China, its own domestic market. Dong Qian, Vice President of the Affiliated Hospital of Qingdao University, who performed the surgery, said: "I'm looking forward to rapid and wide application of Higemi's high-tech medical innovation, in a move to benefit both surgeons and patients across the country."

Several years ago, Hisense had started tapping the medical electronics industry by setting up key technology labs and engaging in the research and development of advanced technologies for medical applications. Hisense has joined hands with its display technology research unit in recent years to take advantage of Hisense's strengths in display and image processing techniques in the development of medical display equipment as well as in the development of surgical simulation techniques and commercial software and hardware focused on a "workstation + mobile display platform" leveraging the mobile internet and cloud technologies.

The medical electronics industry has traditionally been as considered a promising path for electronics producers. Consumer electronics giants such as GE, Philips, Siemens, Samsung, Sony, Canon, Toshiba and NEC have expanded into the sector. China's medical electronics industry is expected to reach 190 billion yuan (approx. US$31 billion) in 2013 and 340 billion yuan (approx. US$56 billion) in 2015.

Hisense has collaborated with renowned hospitals including Beijing Hospital, Qilu Hospital and Affiliated Hospital of Qingdao University as well as academic institutes on joint development projects and development of clinical medical applications. The company plans to set up a specialized medical electronics subsidiary in the future after its initial efforts has been proven.


'/>"/>
SOURCE Hisense Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
2. The Story of the $1,700 Vasectomy Reversal
3. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
4. Medical Device Developers - Network at BIOMEDevice Boston Next Week
5. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
6. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
7. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
8. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
10. Essential Medical Dismisses Patent Case against Masimo and Cercacor
11. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):